Publication | Closed Access

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

Long-acting PasireotideOncologyMedicineClinical TrialsPathologyBronchial NeoplasmAdvanced CarcinoidsCancer TreatmentPharmacologyRadiation OncologyLung CancerCancer ResearchHealth Sciences